Steering Committee

  • David Ayares, Ph.D., President and CEO, Revivicor
  • Robert Capon, Senior Vice President, Adenosine Therapeutics Group, Clinical Data, Inc.
  • Ken Carter, President and CEO, Avalon Pharmaceuticals, Inc.
  • Doug Doerfler, President and CEO, MaxCyte, Inc.
  • Brandon Price, Ph.D., Principal Consultant, Falcon Ridge Associates
  • Bruce Robertson, Managing Director, H.I.G. Ventures
  • Edward Rudnic, Chairman, Tech Council of Maryland
  • Ryan Schwarz, Managing Director, The Carlyle Group
  • Robert T. Skunda, President and CEO, Virginia Biotechnology Research Park
  • John Uhrin, Venture Partner, Harbert Venture Partners

Host Committee

  • Mark Herzog, Executive Director, Virginia Biotechnology Association (VaBIO)
  • Julia Spicer, Executive Director, Mid-Atlantic Venture Association (MAVA)
  • Richard Zakour, Executive Director, MdBio Division of the Tech Council Of Maryland